| Carolyn Buchanan, CCC-SLP | |
|
57 Regional Dr, Suite 7, Concord, NH 03301-8518 | |
| (603) 226-2900 | |
| (603) 226-2907 |
| Full Name | Carolyn Buchanan |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 57 Regional Dr, Concord, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437588209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1511 (New Hampshire) | Primary |
| Provider Name | University Of Central Florida |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568497527 PECOS PAC ID: 9739181470 Enrollment ID: O20070208000253 |
News Archive
One of the most effective measures for containing the transmission of a virus is to identify who an infected person has been in contact and/or crossed paths with, mainly during incubation periods.
Failure to launch an adequate immune response may be at the root of septic shock, according to a study published in The Journal of Experimental Medicine on December 17th.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that it has received a $244,479 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA). The grant was related to the development of ImmunGene's technology which is based on antibody-cytokine fusions that have demonstrated targeted toxicity and added tumor benefits.
A Loyola University Medical Center surgeon is using electrical stimulation as part of an advanced surgical technique to treat Bell's palsy. Bell's palsy is a condition that causes paralysis on one side of a patient's face.
COPD (chronic obstructive pulmonary disease) is one of the most common fatal diseases worldwide. In Germany alone, there are about 3-5 million patients affected. COPD includes both chronic obstructive bronchitis and emphysema. Both represent irreversible changes of the central and lower respiratory tract which are accompanied by coughing, mucus production and difficulty in breathing.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carolyn Buchanan, CCC-SLP 57 Regional Dr, Suite 7, Concord, NH 03301-8518 Ph: (603) 226-2900 | Carolyn Buchanan, CCC-SLP 57 Regional Dr, Suite 7, Concord, NH 03301-8518 Ph: (603) 226-2900 |
News Archive
One of the most effective measures for containing the transmission of a virus is to identify who an infected person has been in contact and/or crossed paths with, mainly during incubation periods.
Failure to launch an adequate immune response may be at the root of septic shock, according to a study published in The Journal of Experimental Medicine on December 17th.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that it has received a $244,479 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA). The grant was related to the development of ImmunGene's technology which is based on antibody-cytokine fusions that have demonstrated targeted toxicity and added tumor benefits.
A Loyola University Medical Center surgeon is using electrical stimulation as part of an advanced surgical technique to treat Bell's palsy. Bell's palsy is a condition that causes paralysis on one side of a patient's face.
COPD (chronic obstructive pulmonary disease) is one of the most common fatal diseases worldwide. In Germany alone, there are about 3-5 million patients affected. COPD includes both chronic obstructive bronchitis and emphysema. Both represent irreversible changes of the central and lower respiratory tract which are accompanied by coughing, mucus production and difficulty in breathing.
› Verified 8 days ago
Nicole Mcaree, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Pillsbury St Ste 404, Concord, NH 03301 Phone: 603-228-7827 | |
Ms. Laura A Darling, M.S.CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Bridge St Ste 1a, Concord, NH 03301 Phone: 603-224-1551 Fax: 603-224-1330 | |
Christopher Paul Doherty, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 144 South St, Concord, NH 03301 Phone: 603-225-0862 | |
Patricia Morrell, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 152 South St, Concord, NH 03301 Phone: 603-225-0827 | |
Ms. Wanda Moulton Denoncour, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 Sewalls Falls Rd, Concord, NH 03301 Phone: 603-225-0853 | |
Mrs. Andrea Parker, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Fisherville Rd Unit 20, Concord, NH 03303 Phone: 603-410-7577 | |
Elizabeth Sirois, SLP-CFY/NH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 239 Pleasant St, Pleasant View Center, Concord, NH 03301 Phone: 603-224-6561 |